Total Payments
$6,789
2024 Payments
$2,321
Companies
29
Transactions
463
Medicare Patients
1,897
Medicare Billing
$72,989
Payment Breakdown by Category
Food & Beverage$6,727 (99.1%)
Education$61.75 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,727 | 459 | 99.1% |
| Education | $61.75 | 4 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,651 | 167 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $980.18 | 90 | $0 (2024) |
| Janssen Biotech, Inc. | $925.87 | 73 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $436.13 | 30 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $296.66 | 20 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $202.67 | 7 | $0 (2024) |
| PFIZER INC. | $191.31 | 11 | $0 (2023) |
| QOL Medical, LLC | $148.58 | 10 | $0 (2023) |
| GENZYME CORPORATION | $148.57 | 8 | $0 (2024) |
| RedHill Biopharma Inc. | $78.45 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,321 | 129 | ABBVIE INC. ($934.08) |
| 2023 | $1,718 | 108 | ABBVIE INC. ($684.23) |
| 2022 | $1,479 | 115 | ABBVIE INC. ($649.34) |
| 2021 | $1,271 | 111 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($394.08) |
All Payment Transactions
463 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: VIROLOGY | ||||||
| 12/18/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/11/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: LIVER DISEASE | ||||||
| 12/03/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 12/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $7.62 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $10.14 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/21/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.78 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Immunology | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $5.06 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Gastroenterology | ||||||
| 11/14/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Rare Disease | ||||||
| 10/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 478 | 503 | $80,076 | $15,238 |
| 2022 | 2 | 428 | 443 | $74,230 | $16,002 |
| 2021 | 4 | 587 | 601 | $100,804 | $25,918 |
| 2020 | 4 | 404 | 404 | $62,070 | $15,830 |
Total Patients
1,897
Total Services
1,951
Medicare Billing
$72,989
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Facility | 2023 | 328 | 328 | $57,072 | $8,765 | 15.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 111 | 132 | $18,876 | $5,455 | 28.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 39 | 43 | $4,128 | $1,019 | 24.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 246 | 246 | $42,804 | $7,877 | 18.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 62 | 77 | $11,011 | $4,047 | 36.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Facility | 2022 | 105 | 105 | $18,270 | $3,407 | 18.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 15 | 15 | $2,145 | $671.40 | 31.3% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 396 | 396 | $68,904 | $15,744 | 22.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 94 | 104 | $14,872 | $5,608 | 37.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 47 | 47 | $11,844 | $2,594 | 21.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 50 | 54 | $5,184 | $1,973 | 38.1% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 273 | 273 | $39,270 | $10,139 | 25.8% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 30 | 30 | $7,284 | $2,013 | 27.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 34 | 34 | $4,890 | $1,602 | 32.8% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Facility | 2020 | 33 | 33 | $5,742 | $913.39 | 15.9% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 23 | 23 | $2,112 | $596.40 | 28.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 11 | 11 | $2,772 | $566.28 | 20.4% |
About Beth Wimer, CRNP
Beth Wimer, CRNP is a Nurse Practitioner healthcare provider based in Meadville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932189941.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Beth Wimer, CRNP has received a total of $6,789 in payments from pharmaceutical and medical device companies, with $2,321 received in 2024. These payments were reported across 463 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($6,727).
As a Medicare-enrolled provider, Wimer has provided services to 1,897 Medicare beneficiaries, totaling 1,951 services with total Medicare billing of $72,989. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Meadville, PA
- Active Since 01/18/2006
- Last Updated 04/27/2023
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1932189941
Products in Payments
- XIFAXAN (Drug) $791.44
- LINZESS (Drug) $669.04
- STELARA (Biological) $518.10
- SKYRIZI (Biological) $511.52
- RINVOQ (Biological) $480.12
- DUPIXENT (Biological) $429.36
- CREON (Drug) $411.30
- ENTYVIO (Biological) $308.61
- HUMIRA (Biological) $266.69
- MAVYRET (Drug) $245.79
- TREMFYA (Drug) $234.04
- XELJANZ (Drug) $191.31
- REMICADE (Biological) $173.73
- REBYOTA (Biological) $154.83
- TRULANCE (Drug) $143.74
- ZENPEP (Drug) $105.23
- Sucraid (Drug) $83.39
- ZYMFENTRA (Biological) $77.23
- VIBERZI (Drug) $66.55
- SUCRAID (Drug) $65.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Meadville
Carrie Stubenhofer, Fnp-C, FNP-C
Nurse Practitioner — Payments: $3,749
Nurse Practitioner $3,749
Melinda Douglas, Crnp, CRNP
Nurse Practitioner — Payments: $3,169
Nurse Practitioner $3,169
Ms. Julie Knapka, Crnp, CRNP
Nurse Practitioner — Payments: $1,932
Nurse Practitioner $1,932
Sarah Oliver, Np, NP
Nurse Practitioner — Payments: $1,412
Nurse Practitioner $1,412
Sharon Palotas, Crnp, CRNP
Nurse Practitioner — Payments: $1,038
Nurse Practitioner $1,038
Julie Myers
Nurse Practitioner — Payments: $945.08
Nurse Practitioner $945.08